Latest News and Press Releases
Want to stay updated on the latest news?
-
Xealth announced an investment from Morningside Ventures, further bringing digital interventions within clinician workflows and to specific populations
-
Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunitiesDr. Sabine Häussermann transitions to newly created role of Chief...
-
Pune, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Digital Therapeutics Market Size & Growth Analysis: According to SNS Insider, The Digital Therapeutics Market, valued at USD 6.3 billion in 2023, is...
-
Arlington, VA, April 16, 2024 (GLOBE NEWSWIRE) -- Digital Therapeutics Alliance is excited to announce the launch of the highly anticipated agenda for the upcoming 2024 DTA Summit. The DTA Summit...
-
DTx Alliance Releases Report Supporting Health Plans Through DTx Integration and Workflow Challenges
Arlington, VA, April 11, 2024 (GLOBE NEWSWIRE) -- A new report was released by Digital Therapeutics Alliance (DTA) to support health plans efforts to adopt digital therapeutic products (DTx). The...
-
Jersey City, NJ, July 25, 2023 (GLOBE NEWSWIRE) -- The Global Digital Therapeutics (DTx) for Mental Health Market is estimated to exhibit a CAGR of 27.42% during the forecast period. DTx...
-
LOS ANGELES and MUMBAI, India and PARIS, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Wellthy Therapeutics, the leader in advancing access to digital care in all parts of the world, today announced the...
-
Austin, Texas, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Austin Regional Clinic (ARC) is partnering with Cognoa, a leading pediatric behavioral health company, on a national multi-site clinical trial to...
-
Austin, Texas, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Austin Regional Clinic (ARC) is partnering with Cognoa, a leading pediatric behavioral health company, on a national multi-site clinical trial to...
-
ROCHESTER, Mich., Sept. 05, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX) to acquire RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity....